Clinical Trial Update: [18F]MK-3328 as a Possible Novel Positron Emission Tomography (PET) Tracer for the Detection of Brain Amyloid Plaques (MK-3328-002) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating [18F]MK-3328 as a potential PET tracer for detecting brain amyloid plaques in Alzheimer's disease; trial terminated with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• [18F]MK-3328

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 1 | Status: TERMINATED | Results posted: 2014-02-20